Literature DB >> 12368909

Thymocyte expression of cathepsin L is essential for NKT cell development.

Karen Honey1, Kamel Benlagha, Courtney Beers, Katherine Forbush, Luc Teyton, Monique J Kleijmeer, Alexander Y Rudensky, Albert Bendelac.   

Abstract

CD1d antigen presentation to natural killer T (NKT) cells expressing the semi-invariant T cell receptor V(alpha)14J(alpha)18 requires CD1d trafficking through endosomal compartments; however, the endosomal events remain undefined. We show that mice lacking the endosomal protease cathepsin L (catL) have greatly reduced numbers of V(alpha)14(+)NK1.1(+) T cells. In addition, catL expression in thymocytes is critical not only for selection of these cells in vivo but also for stimulation of V(alpha)14(+)NK1.1(+) T cells in vitro. CD1d cell-surface expression and intracellular localization appear normal in catL-deficient thymocytes, as does the lysosomal morphology; this implies a specific role for catL in regulating presentation of natural CD1d ligands mediating V(alpha)14(+)NK1.1(+) T cell selection. These data implicate lysosomal proteases as key regulators of not only classical major histocompatibility complex class II antigen presentation but also nonclassical CD1d presentation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368909     DOI: 10.1038/ni844

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  36 in total

Review 1.  Innate self recognition by an invariant, rearranged T-cell receptor and its immune consequences.

Authors:  Aleksandar K Stanic; Jang-June Park; Sebastian Joyce
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

Review 2.  Specialized roles for cysteine cathepsins in health and disease.

Authors:  Jochen Reiser; Brian Adair; Thomas Reinheckel
Journal:  J Clin Invest       Date:  2010-10-01       Impact factor: 14.808

Review 3.  Lipid antigens in immunity.

Authors:  C Marie Dowds; Sabin-Christin Kornell; Richard S Blumberg; Sebastian Zeissig
Journal:  Biol Chem       Date:  2014-01       Impact factor: 3.915

Review 4.  Engineered nanomaterial-induced lysosomal membrane permeabilization and anti-cathepsin agents.

Authors:  Melisa Bunderson-Schelvan; Andrij Holian; Raymond F Hamilton
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017       Impact factor: 6.393

Review 5.  The ins and outs of type I iNKT cell development.

Authors:  Susannah C Shissler; Tonya J Webb
Journal:  Mol Immunol       Date:  2018-11-28       Impact factor: 4.407

6.  Transcription factor Bcl11b controls selection of invariant natural killer T-cells by regulating glycolipid presentation in double-positive thymocytes.

Authors:  Diana I Albu; Jeffrey VanValkenburgh; Nicole Morin; Danielle Califano; Nancy A Jenkins; Neal G Copeland; Pentao Liu; Dorina Avram
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-28       Impact factor: 11.205

7.  Nonobese diabetic mice express aspects of both type 1 and type 2 diabetes.

Authors:  Rodolfo José Chaparro; Yves Konigshofer; Georg F Beilhack; Judith A Shizuru; Hugh O McDevitt; Yueh-Hsiu Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-08       Impact factor: 11.205

8.  Critical role for invariant chain in CD1d-mediated selection and maturation of Vα14-invariant NKT cells.

Authors:  Fenna C M Sillé; Constance Martin; Pushpa Jayaraman; Alissa Rothchild; Gurdyal S Besra; Samuel M Behar; Marianne Boes
Journal:  Immunol Lett       Date:  2011-05-05       Impact factor: 3.685

9.  Promiscuous processing of human alphabeta-protryptases by cathepsins L, B, and C.

Authors:  Quang T Le; Hae-Ki Min; Han-Zhang Xia; Yoshihiro Fukuoka; Nobuhiko Katunuma; Lawrence B Schwartz
Journal:  J Immunol       Date:  2011-05-11       Impact factor: 5.422

10.  CD1c bypasses lysosomes to present a lipopeptide antigen with 12 amino acids.

Authors:  Ildiko Van Rhijn; David C Young; Annemieke De Jong; Jenny Vazquez; Tan-Yun Cheng; Rahul Talekar; Duarte C Barral; Duarte Barral; Luis León; Michael B Brenner; Joel T Katz; Richard Riese; Ruth M Ruprecht; Peter B O'Connor; Catherine E Costello; Steven A Porcelli; Volker Briken; D Branch Moody
Journal:  J Exp Med       Date:  2009-05-25       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.